arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ALX ONCOLOGY HOLDINGS INC

ALXO
$2.09 ▼ -0.04 (-1.88%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
31 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
43
Health
Weak
Neutral
auto_awesome

Analytical Summary

ALX ONCOLOGY HOLDINGS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $218.6M
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC -9.4%
FCF / Share $-0.18
Trailing P/E
Price / Book 1.9x
FCF Yield
Debt / Equity 0.06
info Valuation on last close. End-of-day price, Aug 7, 2026.

31-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-17.93M
↑ +41.7%
Operating Margin Operating profit as % of sales
-241.6%
↑ +25.3%
FCF / Share Free cash flow per share
$-0.18
↑ +61.4%
Long-Term Debt Long-term obligations
$8.86M
↓ -12.8%

Health Breakdown

Financial Health
36
Cash Quality
56

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 31 quarters